Stephan Christgau

Chairman at

Venture Cup Foundation

62 year

20 connections

Health Technology

Commercial Services

Finance

Profile

Stephan Christgau currently works at Venture Cup Foundation, as Chairman, Octarine Bio ApS, as Chairman from 2020, Life Science Legal ApS, as Director, IO Biotech ApS, as Director, Scenic Biotech BV, as Non-Executive Director, Eir Ventures Danmark ApS, as Managing Partner from 2020, and Eir Ventures Partners AB, as General Partner from 2020.
Dr. Christgau also formerly worked at Thrombologic ApS, as Chairman, PCOVERY ApS, as Chairman, Organon R&D Finland Oy, as Chairman from 2013 to 2020, EpiTherapeutics ApS, as Director, Inagen ApS, as Director, Aros Pharma ApS, as Director, Adenium Biotech ApS, as Director, Acesion Pharma ApS, as Director, Galecto Biotech ApS, as Director, Lysogene SA, as Executive Director, NMD Pharma A, as Director, HepaRegeniX GmbH, as Director, AFYX Therapeutics AS, as Director, Novo Holdings A, as Investment Director from 2017 to 2019, Damora Therapeutics, Inc., as Director from 2020 to 2021, Novo Nordisk A, as Research Scientist, Osteologix, Inc., as Chief Operating Officer & Secretary, Osteometer Biotech AS, as Senior Research Scientist, Osteologix Holdings Plc, as Chief Operating Officer & Executive Vice President, Immunodiagnostic Systems Nordic A, as Senior Research Scientist, and Novo Seeds, as Partner from 2007 to 2019.
Dr. Christgau received his doctorate degree from The University of California, San Francisco and graduate degree from Technical University of Denmark.

Stephan Christgau active positions

Companies	Position	Start
IO Biotech ApS IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies	Director/Board Member	-
Venture Cup Foundation	Chairman	-
Octarine Bio IVS Octarine Bio IVS BiotechnologyHealth Technology Manufactures bio-based pigments, dyes and ingredients using synthetic biology & precision fermentation	Chairman	30/06/2020
Eir Ventures Danmark ApS Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	01/07/2020
iSD Immunotech ApS iSD Immunotech ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in natural sciences & engineering	Director/Board Member	-
Scenic Biotech BV Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics	Director/Board Member	-
Eir Ventures Partners AB Eir Ventures Partners AB Investment ManagersFinance Eir Ventures Partners invests in companies located in Sweden. The firm targets companies operating in the fields of life science, medical technology, new therapies and digital health service sectors. It provides financing for pre-seed, seed and early stage capital requirements.	Private Equity Investor	01/01/2020

All active positions of Stephan Christgau

Former positions of Stephan Christgau

Companies	Position	End
DAMORA THERAPEUTICS, INC.	Director/Board Member	26/05/2021
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health	Chairman	01/07/2020
░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░	░░░░░ ░░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░░ ░░░	░░░░░░░░	░░░░░░░░░░

See the detail of Stephan Christgau's experience

Training of Stephan Christgau

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephan Christgau's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	30
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Osteologix, Inc. /Old/ Osteologix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology
Osteometer Biotech AS Osteometer Biotech AS BiotechnologyHealth Technology Develops treatments for bone disorders	Health Technology
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Technical University of Denmark Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Osteologix Holdings Plc Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Operates as an investment holding company with interest in development of pharmaceuticals	Health Technology
Immunodiagnostic Systems Nordic A/S Immunodiagnostic Systems Nordic A/S Medical SpecialtiesHealth Technology Develops diagnostic testing kits for clinical and research markets	Health Technology
EpiTherapeutics ApS EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics	Health Technology
Inagen ApS Inagen ApS Miscellaneous Commercial ServicesCommercial Services Develops novel biopharmaceuticals for anti-viral treatment and provides medical research services	Commercial Services
Novo Seeds Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement.	Finance
Venture Cup Foundation
Thrombologic ApS Thrombologic ApS Miscellaneous Commercial ServicesCommercial Services Provides medical research and develops therapeutics	Commercial Services
Aros Pharma ApS Aros Pharma ApS Pharmaceuticals: MajorHealth Technology Develops a therapy for the treatment of gastrointestinal pain	Health Technology
Pcovery ApS Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections	Health Technology
Adenium Biotech ApS Adenium Biotech ApS Pharmaceuticals: MajorHealth Technology Provides novel antibiotics for the treatment of multi drug resistant bacterial infections	Health Technology
Acesion Pharma ApS Acesion Pharma ApS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures antiarrhythmic drugs for treatment of atrial fibrillation	Commercial Services
iSD Immunotech ApS iSD Immunotech ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in natural sciences & engineering	Commercial Services
Galecto Biotech ApS Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer	Health Technology
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health	Health Technology
Lysogene SA Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders	Health Technology
IO Biotech ApS IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies	Health Technology
NMD Pharma A/S NMD Pharma A/S BiotechnologyHealth Technology Discovers and develops novel therapeutics for neuromuscular diseases	Health Technology
HepaRegeniX GmbH HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases	Health Technology
AFYX Therapeutics AS AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Scenic Biotech BV Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics	Commercial Services
Novo Holdings A/S (Investment Company) Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives.	Finance
Galecto, Inc. Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases	Health Technology
Octarine Bio IVS Octarine Bio IVS BiotechnologyHealth Technology Manufactures bio-based pigments, dyes and ingredients using synthetic biology & precision fermentation	Health Technology
Eir Ventures Partners AB Eir Ventures Partners AB Investment ManagersFinance Eir Ventures Partners invests in companies located in Sweden. The firm targets companies operating in the fields of life science, medical technology, new therapies and digital health service sectors. It provides financing for pre-seed, seed and early stage capital requirements.	Finance
Eir Ventures Danmark ApS Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager	Finance